TAS 102 mechanism of action compared to 5-FU
Por um escritor misterioso
Descrição
Cancers, Free Full-Text
Therapeutic potential of TAS-102 in the treatment of
Frontiers A Comparison of Bevacizumab Plus TAS-102 and TAS-102
Redefining Later-Line Therapy in Metastatic Colorectal Cancer - EMJ
The mechanism underlying resistance to 5‑fluorouracil and its
Regulation of thymidylate synthase: an approach to overcome 5-FU
The mechanism underlying resistance to 5‑fluorouracil and its
Efficacy of Combination Chemotherapy Using a Novel Oral
Colorectal Cancer: Individualizing Therapy Beyond Second-line
Dihydrofluorouracil - an overview
5-Fluorouracil (5-FU) resistance and the new strategy to enhance
Pharmacological effects of the simultaneous and sequential
